SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-027973
Filing Date
2023-06-14
Accepted
2023-06-14 16:31:15
Documents
93
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 20-F vrax-20230331.htm   iXBRL 20-F 3746855
2 EX-8.1 vrax-ex8_1.htm EX-8.1 14107
3 EX-10.10 vrax-ex10_10.htm EX-10.10 548846
4 EX-10.11 vrax-ex10_11.htm EX-10.11 287050
5 EX-12.1 vrax-ex12_1.htm EX-12.1 11167
6 EX-12.2 vrax-ex12_2.htm EX-12.2 10484
7 EX-13.1 vrax-ex13_1.htm EX-13.1 9294
8 EX-13.2 vrax-ex13_2.htm EX-13.2 9295
9 GRAPHIC img133848506_0.jpg GRAPHIC 69505
10 GRAPHIC img133848506_1.jpg GRAPHIC 5387
  Complete submission text file 0000950170-23-027973.txt   12144954

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrax-20230331_cal.xml EX-101.CAL 45241
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrax-20230331_pre.xml EX-101.PRE 410392
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrax-20230331_def.xml EX-101.DEF 274690
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrax-20230331.xsd EX-101.SCH 92012
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrax-20230331_lab.xml EX-101.LAB 508114
87 EXTRACTED XBRL INSTANCE DOCUMENT vrax-20230331_htm.xml XML 1940969
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41440 | Film No.: 231014551
SIC: 2835 In Vitro & In Vivo Diagnostic Substances